Danicopan Interactions
There are 216 drugs known to interact with danicopan, along with 2 disease interactions. Of the total drug interactions, 41 are major, 161 are moderate, and 14 are minor.
- View danicopan disease interactions (2)
Medications known to interact with danicopan
Note: Showing generic names only.
- abrocitinib
- adalimumab
- afatinib
- alefacept
- alemtuzumab
- aliskiren
- allogeneic processed thymus tissue
- alpelisib
- alvimopan
- anakinra
- apixaban
- armodafinil
- artesunate
- ashwaganda
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- atezolizumab
- atorvastatin
- avelumab
- azathioprine
- baricitinib
- bcg
- bedaquiline
- berotralstat
- betrixaban
- bifidobacterium infantis
- bifidobacterium longum
- black cohosh
- bosutinib
- brentuximab
- brewer's yeast
- cabazitaxel
- calaspargase pegol
- canakinumab
- cannabidiol
- cat's claw
- cemiplimab
- ceritinib
- certolizumab
- cladribine
- clofarabine
- cobimetinib
- colchicine
- cosibelimab
- cyclosporine
- dabigatran
- daclatasvir
- daclizumab
- darolutamide
- daunorubicin
- daunorubicin liposomal
- delafloxacin
- denosumab
- deucravacitinib
- dextromethorphan
- digoxin
- dimethyl fumarate
- diroximel fumarate
- docetaxel
- dostarlimab
- doxorubicin
- doxorubicin liposomal
- durvalumab
- echinacea
- edoxaban
- efalizumab
- efavirenz
- elagolix
- elderberry
- eliglustat
- eltrombopag
- empagliflozin
- enfortumab vedotin
- epirubicin
- erlotinib
- erythromycin
- etanercept
- etoposide
- etranacogene dezaparvovec
- etrasimod
- everolimus
- idarubicin
- idelalisib
- imatinib
- indacaterol
- infliximab
- interferon beta-1a
- interferon beta-1b
- ipilimumab
- iptacopan
- irinotecan
- irinotecan liposomal
- isoniazid
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- lapatinib
- larotrectinib
- leflunomide
- lemborexant
- letermovir
- levoketoconazole
- linagliptin
- lomitapide
- loncastuximab tesirine
- loperamide
- lurasidone
- lusutrombopag
- maraviroc
- mavorixafor
- methadone
- methotrexate
- mibefradil
- mipomersen
- mitoxantrone
- monomethyl fumarate
- morphine
- nadofaragene firadenovec
- naldemedine
- naloxegol
- naltrexone
- natalizumab
- nilotinib
- nintedanib
- niraparib
- nivolumab
- paclitaxel
- pazopanib
- pegaspargase
- peginterferon beta-1a
- pembrolizumab
- penpulimab
- pexidartinib
- ponesimod
- posaconazole
- pralsetinib
- pretomanid
- ranolazine
- relugolix
- remdesivir
- repotrectinib
- retifanlimab
- rifampin
- rifaximin
- rilonacept
- rimegepant
- riociguat
- ripretinib
- ritlecitinib
- ritonavir
- rivaroxaban
- roflumilast
- romidepsin
- rosuvastatin
- rucaparib
- ruxolitinib topical
- saccharomyces boulardii lyo
- seladelpar
- selexipag
- silodosin
- siponimod
- sipuleucel-T
- sirolimus
- sirolimus protein-bound
- streptococcus salivarius
- sulfasalazine
- tacrolimus
- talazoparib
- talimogene laherparepvec
- tenofovir alafenamide
- tenofovir disoproxil
- tepotinib
- terfenadine
- teriflunomide
- thioguanine
- ticagrelor
- tipranavir
- tislelizumab
- tofacitinib
- tolvaptan
- topotecan
- toripalimab
- trabectedin
- tremelimumab
- valoctocogene roxaparvovec
- vemurafenib
- venetoclax
- vibegron
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- vitamin e
- voclosporin
Danicopan disease interactions
There are 2 disease interactions with danicopan which include:
Report options
More about danicopan
- danicopan consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Ultomiris
Ultomiris (ravulizumab-cwvz) is used for the treatment of myasthenia gravis, paroxysmal nocturnal ...
Fabhalta
Fabhalta is used to treat paroxysmal nocturnal hemoglobinuria (PNH), primary immunoglobulin A ...
Empaveli
Empaveli (pegcetacoplan) is an immunosuppressant that is given by subcutaneous (under the skin) ...
Soliris
Soliris infusion is used to treat paroxysmal nocturnal hemoglobinuria (PNH) or neuromyelitis optica ...
Voydeya
Voydeya (danicopan) is an oral complement factor D inhibitor that may be used to treat ...
Bkemv
Bkemv (eculizumab-aeeb) is an interchangeable biosimilar to Soliris which may be used to treat ...
Epysqli
Epysqli (eculizumab-aagh), a biosimilar to Soliris, targets the complement system to treat ...
Pegcetacoplan
Pegcetacoplan (brand name Empaveli) is a twice-weekly, injectable medicine that may be used to ...
Iptacopan
Iptacopan is used to treat paroxysmal nocturnal hemoglobinuria (PNH), primary immunoglobulin A ...
Ravulizumab
Ravulizumab-cwvz is used to treat myasthenia gravis (gMG), hemolytic uremic syndrome (aHUS) ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.